312 related articles for article (PubMed ID: 37951857)
21. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
22. Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review.
Pittayanon R; Lau JT; Leontiadis GI; Tse F; Yuan Y; Surette M; Moayyedi P
Gastroenterology; 2020 Mar; 158(4):930-946.e1. PubMed ID: 31812509
[TBL] [Abstract][Full Text] [Related]
23. Integrated Analysis of Microbiome and Metabolome Reveals Disease-Specific Profiles in Inflammatory Bowel Diseases and Intestinal Behçet's Disease.
Park Y; Ahn JB; Kim DH; Park IS; Son M; Kim JH; Ma HW; Kim SW; Cheon JH
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928402
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiota signatures in inflammatory bowel disease.
Vestergaard MV; Allin KH; Eriksen C; Zakerska-Banaszak O; Arasaradnam RP; Alam MT; Kristiansen K; Brix S; Jess T
United European Gastroenterol J; 2024 Feb; 12(1):22-33. PubMed ID: 38041519
[TBL] [Abstract][Full Text] [Related]
25. Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.
Rengarajan S; Vivio EE; Parkes M; Peterson DA; Roberson EDO; Newberry RD; Ciorba MA; Hsieh CS
Gut Microbes; 2020 May; 11(3):405-420. PubMed ID: 31203722
[TBL] [Abstract][Full Text] [Related]
26. Microbial Dynamics in Newly Diagnosed and Treatment Naïve IBD Patients in the Mediterranean.
Rausch P; Ellul S; Pisani A; Bang C; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
Inflamm Bowel Dis; 2023 Jul; 29(7):1118-1132. PubMed ID: 36735955
[TBL] [Abstract][Full Text] [Related]
27. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
[TBL] [Abstract][Full Text] [Related]
28. Seasonal variations in gut microbiota and disease course in patients with inflammatory bowel disease.
Tani M; Shinzaki S; Asakura A; Tashiro T; Amano T; Otake-Kasamoto Y; Yoshihara T; Yoshii S; Tsujii Y; Hayashi Y; Inoue T; Motooka D; Nakamura S; Iijima H; Takehara T
PLoS One; 2023; 18(4):e0283880. PubMed ID: 37071621
[TBL] [Abstract][Full Text] [Related]
29. Fecal transplantation for treatment of inflammatory bowel disease.
Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
[TBL] [Abstract][Full Text] [Related]
30. Persistent Diarrhea in Patients With Crohn's Disease After Mucosal Healing Is Associated With Lower Diversity of the Intestinal Microbiome and Increased Dysbiosis.
Boland K; Bedrani L; Turpin W; Kabakchiev B; Stempak J; Borowski K; Nguyen G; Steinhart AH; Smith MI; Croitoru K; Silverberg MS
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):296-304.e3. PubMed ID: 32220613
[TBL] [Abstract][Full Text] [Related]
31. Machine Learning Based Metagenomic Prediction of Inflammatory Bowel Disease.
Mihajlović A; Mladenović K; Lončar-Turukalo T; Brdar S
Stud Health Technol Inform; 2021 Oct; 285():165-170. PubMed ID: 34734869
[TBL] [Abstract][Full Text] [Related]
32. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
[TBL] [Abstract][Full Text] [Related]
33. Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer.
Lavelle A; Nancey S; Reimund JM; Laharie D; Marteau P; Treton X; Allez M; Roblin X; Malamut G; Oeuvray C; Rolhion N; Dray X; Rainteau D; Lamaziere A; Gauliard E; Kirchgesner J; Beaugerie L; Seksik P; Peyrin-Biroulet L; Sokol H
Gut Microbes; 2022; 14(1):2078620. PubMed ID: 35638103
[TBL] [Abstract][Full Text] [Related]
34. The microbiome reflects diagnosis and predicts disease severity in paediatric onset inflammatory bowel disease.
Malham M; Lilje B; Houen G; Winther K; Andersen PS; Jakobsen C
Scand J Gastroenterol; 2019 Aug; 54(8):969-975. PubMed ID: 31329473
[No Abstract] [Full Text] [Related]
35. Gut microbiome diversity in acute infective and chronic inflammatory gastrointestinal diseases in North India.
Kedia S; Rampal R; Paul J; Ahuja V
J Gastroenterol; 2016 Jul; 51(7):660-71. PubMed ID: 26994772
[TBL] [Abstract][Full Text] [Related]
36. Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case-control study in India.
Kabeerdoss J; Sankaran V; Pugazhendhi S; Ramakrishna BS
BMC Gastroenterol; 2013 Jan; 13():20. PubMed ID: 23351032
[TBL] [Abstract][Full Text] [Related]
37. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory bowel disease: between genetics and microbiota.
Younis N; Zarif R; Mahfouz R
Mol Biol Rep; 2020 Apr; 47(4):3053-3063. PubMed ID: 32086718
[TBL] [Abstract][Full Text] [Related]
39. DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome.
Howell KJ; Kraiczy J; Nayak KM; Gasparetto M; Ross A; Lee C; Mak TN; Koo BK; Kumar N; Lawley T; Sinha A; Rosenstiel P; Heuschkel R; Stegle O; Zilbauer M
Gastroenterology; 2018 Feb; 154(3):585-598. PubMed ID: 29031501
[TBL] [Abstract][Full Text] [Related]
40. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
